August 2023
Core topics in this month’s edition include:
- Onglyza® (saxagliptin) and Kombiglyze® XR (saxagliptin/metformin, extended release) – first time generics
- Spiriva® HandiHaler® (tiotropium) – first time generic
- Tyruko® (natalizumab-sztn) – new biosimilar approval
- Zurzuvae™ (zuranolone) – new drug approval
Top